AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.

Texas Gov. Greg Abbott has released a 155-page report outlining his plan for the future of business, innovation, ...

It only takes a quick scan of any cable news network to realize that we have entered a whole new age of uncertainty. For many ...

Corporation outlined how ongoing investments will aim to accelerate its strategy and drive billions of dollars of profitable sales ...

In this podcast, Motley Fool analyst Asit Sharma and host Ricky Mulvey discuss: Why Wall Street is shrugging off Nvidia's 78% ...

A compelling and diversified product portfolio helps drive revenues of the Zacks Securities and Exchanges industry players. A ...

As stocks continue sliding off a cliff, it can be difficult to discern which dips may be buying opportunities hiding in plain ...

B2B tech startups often face the challenge of establishing themselves as category leaders while navigating long sales cycles, ...

Stronger social security and unemployment benefits are among the key support measures they would like to see, some Chinese ...

The Zacks Real Estate Operations industry faces disruptions, including geopolitical unrest and macroeconomic challenges, in ...

Chart Industries' 29.4% order intake growth signals strong performance and earnings visibility. See here to know why we ...

Comfort Systems USA has a wide economic moat built upon their scale, industry knowledge, and tangible switching costs for ...